BlackRock Health Sciences Trust offers an 8.3% monthly dividend yield, but coverage is inconsistent. Read why BME is a Buy.
While not a buy, Newmont's risk/reward is more balanced and no longer warrants an avoidant stance. Read more on NEM stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results